The iPro2 myLog app, now powered by Nutrino, a leading AI (artificial intelligence) personalized nutrition analysis platform, is used during a professional iPro2 CGM evaluation for the patient to log their blood glucose (BGs), food and activity. Meal logging is easy; patients simply take a photo of each meal and snack. Upon completion of the 6-day CGM evaluation, the information from the app is synchronized with sensor glucose data and creates two unique reports - the Pattern Snapshot report and the new FoodPrint report. The Pattern Snapshot report shows critical glucose information such as time in target glucose range, identified patterns of glucose variability, and a clear graph of the full glucose tracing. The FoodPrint report shows pictures of meals taken for breakfast, lunch and dinner and scores (A, B, C, D or F) each meal based on the body's glucose reaction. Together these reports help the physician and the patient work together to develop a personalized therapy and treatment plan.
"By making it easier to communicate relevant, personal insights about food's impact on diabetes, Medtronic arms physicians and diabetes educators with a powerful coaching tool that will help drive positive behavior change," said Sheri Dodd, vice president and general manager for Non-Intensive Diabetes Therapies (NDT). "Our partnership with Nutrino to infuse more detail about diet's impact on glucose furthers our goal to make glucose a vital sign in the treatment of diabetes."
Recognizing the important and intertwined impact that food has on diabetes, Medtronic has expanded its partnership with Nutrino, a leader in food data analytics with its flagship FoodPrint technology. Following two years of successful partnering and results, this expanded relationship will embed food data and FoodPrint insights across all the Diabetes Group businesses.
"We are proud to partner with Medtronic to deliver insights through the FoodPrint report, which can help people across the diabetes spectrum to better understand their responses to particular foods," said Yael Glassman, CEO of Nutrino Health. "We're confident that the addition of FoodPrint into the iPro2 professional CGM evaluation will have a positive impact for individuals living with type 2 diabetes."